prednisone
Showing 26 - 50 of 945
Idiopathic Membranous Nephropathy Trial in Beijing (Prednisone, MP and CTX)
Terminated
- Idiopathic Membranous Nephropathy
- Prednisone
- MP and CTX
-
Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Feb 2, 2022
Primary Diffuse Large B-cell Lymphoma of the CNS (CNS), Aggressive B-cell Lymphoma With Secondary Involvement of the CNS Trial
Suspended
- Primary Diffuse Large B-cell Lymphoma of the Central Nervous System (CNS)
- Aggressive B-cell Lymphoma With Secondary Involvement of the CNS
- Obinutuzumab
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 6, 2022
Alcoholic Hepatitis Trial in United States (Anakinra and Zinc, Prednisone, Placebos)
Completed
- Alcoholic Hepatitis
- Anakinra and Zinc
- +2 more
-
Phoenix, Arizona
- +10 more
Sep 13, 2022
Multiple Myeloma, Newly Diagnosed Patients Trial in Torino (Melphalan, Lenalidomide, Prednisone)
Active, not recruiting
- Multiple Myeloma
- Newly Diagnosed Patients
- Melphalan
- +2 more
-
Torino, ItalyDivision of Hematology, AOU Città della Salute e della Scienza d
Mar 24, 2022
Prostatic Tumors Trial in Bronx (Abiraterone Acetate, Prednisone)
Active, not recruiting
- Prostatic Neoplasms
- Abiraterone Acetate
- Prednisone
-
Bronx, New YorkMontefiore Medical Center
Sep 22, 2022
Duchenne Muscular Dystrophy (DMD) Trial in Gainesville (Prednisone, In-home Exercise Training, Prednisone plus exercise)
Recruiting
- Duchenne Muscular Dystrophy (DMD)
- Prednisone
- +2 more
-
Gainesville, FloridaUniversity of Florida
Feb 28, 2022
The Clinical Features and Pregnancy Outcomes of RA Patients
Recruiting
- Rheumatoid Arthritis
- Pregnancy Related
- Prednisone
- +2 more
-
Jinan, Shandong, ChinaQilu Hospital
Dec 6, 2022
Thyroid Diseases Trial in Madison (Prednisone)
Completed
- Thyroid Diseases
- Prednisone
-
Madison, WisconsinUniversity of Wisconsin Hospital and Clinics
Oct 4, 2022
Cystic Fibrosis Pulmonary Exacerbation Trial in Canada (Prednisone, Placebos)
Recruiting
- Cystic Fibrosis Pulmonary Exacerbation
- Prednisone
- Placebos
-
Calgary, Alberta, Canada
- +11 more
Nov 23, 2022
Metastatic Castration-resistant Prostate Cancer Trial in United Kingdom, United States (PLX2853, Olaparib, Abiraterone acetate)
Terminated
- Metastatic Castration-resistant Prostate Cancer
- PLX2853
- +3 more
-
Chicago, Illinois
- +7 more
Oct 4, 2022
Myocarditis, Heart Failure, Endomyocardial Biopsy Trial in Warsaw (Prednisone, Azathioprine, Placebo Prednisone)
Not yet recruiting
- Myocarditis
- +4 more
- Prednisone
- +3 more
-
Warsaw, PolandFirst Department of Cardiology, Medical University of Warsaw
Apr 26, 2022
Prostate Cancer Trial in Canada, United States (Prednisone, Apalutamide, Abiraterone Acetate)
Recruiting
- Prostate Cancer
- Prednisone
- +3 more
-
Boston, Massachusetts
- +5 more
Jul 14, 2022
Lymphoma Trial in China (Brentuximab Vedotin, Cyclophosphamide, Doxorubicin)
Not yet recruiting
- Lymphoma
- Brentuximab Vedotin
- +3 more
-
Beijing, China
- +15 more
Jan 4, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Portland, Seattle
Active, not recruiting
- Castration-Resistant Prostate Carcinoma
- +3 more
- Cabazitaxel
- +4 more
-
Portland, Oregon
- +2 more
Jun 24, 2022
Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Houston (drug, procedure,
Recruiting
- Prostate Carcinoma
- +6 more
- Abiraterone Acetate
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Aug 10, 2022
Immune Thrombocytopenia Trial in Beijing (Cyclosporine Oral Product, Prednisone)
Not yet recruiting
- Immune Thrombocytopenia
- Cyclosporine Oral Product
- Prednisone
-
Beijing, Beijing, ChinaPeking University Insititute of Hematology, Peking University Pe
Jul 14, 2022
Inflammatory Arthritis, Immune-related Adverse Event Trial (Adalimumab, Prednisone)
Not yet recruiting
- Inflammatory Arthritis
- Immune-related Adverse Event
- Adalimumab
- Prednisone
- (no location specified)
Sep 13, 2023
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Duarte
Recruiting
- Castration-Sensitive Prostate Carcinoma
- +4 more
- Abiraterone Acetate
- +7 more
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 7, 2022
B-Cell Lymphoma, Non-Hodgkin Lymphoma Trial in Worldwide (Glofitamab, Obinutuzumab (G), Rituximab (R))
Active, not recruiting
- B-Cell Lymphoma
- Non-Hodgkin Lymphoma
- Glofitamab
- +8 more
-
Birmingham, Alabama
- +23 more
Dec 2, 2022
Androgen-Independent Prostatic Cancer, Androgen-Independent Prostatic Tumors, Prostate Cancer Recurrent Trial (lorigerlimab,
Not yet recruiting
- Androgen-Independent Prostatic Cancer
- +8 more
- lorigerlimab
- +2 more
- (no location specified)
May 4, 2023
Idiopathic Retroperitoneal Fibrosis Trial (Prednisone)
Not yet recruiting
- Idiopathic Retroperitoneal Fibrosis
- Prednisone
- (no location specified)
Jun 17, 2022
Large B-cell Lymphoma Trial in Houston (Prednisone, Rituximab, Cyclophosphamide)
Not yet recruiting
- Large B-cell Lymphoma
- Prednisone
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 19, 2023
Stage III Prostate Adenocarcinoma AJCC v7, Stage III Prostate Cancer AJCC v7, Stage IV Prostate Adenocarcinoma AJCC v7 Trial in
Completed
- Stage III Prostate Adenocarcinoma AJCC v7
- +3 more
- Abiraterone Acetate
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 15, 2021